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The effects of cyclic ADP-ribose (cADPR) and the immunosuppressant drug FK506 on microsomal Ca2 + release through a ryanodine-
sensitive mechanism were investigated in rat pancreatic acinar cells. After a steady state of 45Ca2 + uptake into the microsomal vesicles,
ryanodine or caffeine was added. Preincubation of the vesicles with cADPR (0.5 AM) shifted the dose–response curve of ryanodine- or
caffeine-induced 45Ca2 + release from the vesicles to the left. Preincubation with cADPR shifted the dose–response curve of the FK506-
induced 45Ca2 + release upward. Preincubation with FK506 (3 AM) shifted the dose–response curve of the ryanodine- or caffeine-induced
45Ca2 + release to the left by the same extent as that in the case of cADPR. FK506 shifted the dose–response curve of the cADPR-induced
45Ca2 + release upward. The presence of both cADPR and FK506 enhanced the ryanodine (30 AM)- or caffeine (10 mM)-induced 45Ca2 +
release by the same extent as that in the case of cADPR alone or FK506 alone.
These results indicate that cADPR and FK506 modulate the ryanodine-sensitive Ca2 + release mechanism of rat pancreatic acinar cells by
increasing the ryanodine or caffeine sensitivity to the mechanism. In addition, there is a possibility that the mechanisms of modulation by
cADPR and FK506 are the same.
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1. Introduction [17]. It is also known that a low concentration of cADPRIn excitable cells, the ryanodine-sensitive Ca2 + release
mechanism (ryanodine receptor: RyR), which is activated by
ryanodine, caffeine or Ca2 +, has been well characterized,
and the channel protein has been purified [1,2] and cloned
[3,4]. The ryanodine-sensitive mechanism in nonexcitable
cells such as liver cells and exocrine cells has also been
characterized [5–11].
The endogenous NAD+ metabolite cyclic ADP-ribose
(cADPR), which is thought to be an intracellular messenger
in addition to inositol 1,4,5-trisphosphate (IP3) [12], induces
Ca2 + release from RyRs in sea urchin eggs [13,14], cardiac
muscle cells [15], brain cells [16] and pancreatic h cells0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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proteins have been identified in sea urchin eggs [19].
However, it was suggested from the measurement of mo-
lecular mass that these proteins are different from RyR
proteins. Little is known about the action of cADPR on
the Ca2 + channel.
The immunosuppressant drug FK506 has been shown to
modulate RyRs [20,21]. In the skeletal muscle sarcoplasmic
reticulum (SR), the RyR is known to be tightly associated
with a 12-kDa binding protein [22,23]. The 12-kDa binding
protein is a cytosolic receptor for FK506 and is referred to as
FK506-binding protein (FKBP12). In association with RyR,
FKBP12 has been shown to stabilize the closed conforma-
tion of the Ca2 + release channel [20], and FK506 has been
shown to promote dissociation of FKBP12 from the RyR
complex [20]. Compared with control SR vesicles, FKBP12-
deficient SR vesicles have been shown to increase caffeine
sensitivity to caffeine-induced Ca2 + release [20] and to
increase open probability and mean open times for single
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cells, FKBP12.6 binds to the RyR [25,26]. It has been
suggested that cADPR can dissociate FKBP12.6 from the
RyR in rat pancreatic islets [27]. Although FK506 has been
reported to affect [3H]ryanodine binding to the RyR in
nonexcitable cells [28,29], details of the FK506-dependent
mechanism, including the presence of FKBP, are unclear.
It has been demonstrated that the ryanodine-sensitive
Ca2 + release mechanism, which is activated by Ca2 +,
caffeine, ryanodine or cADPR, operates in the endoplasmic
reticulum (ER) of rat pancreatic acinar cells [7,10,30]. In the
present study, modulatory effects of cADPR and FK506 on
the ryanodine-sensitive Ca2 + channel in rat pancreatic
acinar cells were investigated by using isolated microsomal
vesicles preloaded with 45Ca2 +. It was found that cADPR
and FK506 shift the dose–response curve of ryanodine- or
caffeine-induced 45Ca2 + release from pancreatic microsom-
al vesicles to the left and increase ryanodine or caffeine
sensitivity to the RyR.Fig. 1. Effect of cADPR (0.5 AM) on ryanodine-induced 45Ca2 + release
from pancreatic microsomes. (A) Typical curves for ryanodine (10 AM)-
induced 45Ca2 + release from microsomal vesicles in the absence and
presence of cADPR (0.5 AM). The vesicles (1 mg/ml) were preincubated in
0.6 ml of a KCl buffer containing 45CaCl2 (1 ACi/ml) for 15 min. 45Ca2 +
uptake was initiated by the addition of 2 mM K2ATP (at 0 min). Ryanodine
(Ry., 10 AM) was added to the vesicles as indicated in the absence (Control;
o) and presence (.) of cADPR. cADPR or the same volume of H2O as a
control was added at the beginning of the preincubation. (B) Dose–
response curves of ryanodine (0.1–500 AM)-induced 45Ca2 + release from
the vesicles in the absence (Control; o) and presence (.) of cADPR (0.5
AM). The vertical line represents the ratio of released 45Ca2 + over a 6-min
period after the addition of ryanodine to the 45Ca2 + that had been taken up
by an ATP-dependent mechanism. Each point is the meanF S.E. from 5 to
10 experiments of the type shown in (A). Note that cADPR shifted the
dose– response curve of the ryanodine-induced 45Ca2 + release to the left.
Asterisks indicate the level of significant difference compared to the control
without cADPR at the corresponding ryanodine concentration. *P < 0.05,
**P< 0.01, ***P < 0.001.2. Materials and methods
2.1. Materials
Creatine kinase and trypsin inhibitor were obtained from
Boehringer Mannheim (Mannheim, Germany). Adenosine
trisphosphate dipotassium salt (K2ATP), creatine phosphate
disodium salt and benzamidine were purchased from Sigma
Chemical (St. Louis, MO, USA). FK506 was kindly pro-
vided by Fujisawa Pharmaceutical Co., Ltd. (Osaka, Japan).
cADPR was obtained from Wako Pure Chemical (Osaka,
Japan). Ryanodine was obtained from Calbiochem (La Jolla,
CA, USA). 45CaCl2 (14–15 Ci/g) was purchased from New
England Nuclear (Boston, MA, USA).
2.2. Preparation of microsomal vesicles
Pancreatic microsomal vesicles were prepared as de-
scribed previously [7,31,32]. Briefly, isolated acinar cells
from male Wistar rats (180–200 g) were homogenized in an
ice-cold ‘‘mannitol buffer’’ containing: 290 mM mannitol,
10 mM KCl, 5 mM HEPES, 1 mM MgCl2, 1 mM benzami-
dine, 0.2 mM phenylmethylsulfonyl fluoride, and 20 Ag/ml
of trypsin inhibitor, adjusted with Tris to pH 7.0. After
centrifugation of the cell homogenate at 11,000 g for 15
min, the ‘‘fluffy layer’’ on top of the pellet, which is enriched
by about twofold in the ER [31], was collected. The
microsomal vesicles were kept frozen in liquid nitrogen until
use. The protein concentration was measured by the method
of Bradford [33] using bovine serum albumin as a standard.
2.3. Measurement of 45Ca2+ uptake
Isolated membrane vesicles were preincubated for 15
min at a protein concentration of 1.0 mg/ml in 0.6 ml of anincubation buffer containing: 155 mM KCl, 5 mM HEPES,
0.15 mM CaCl2 (corresponding to 2 AM free Ca2 + concen-
tration), 1.0 mM EDTA, 3.57 mM MgCl2 (corresponding to
1.0 mM free Mg2 + concentration), 10 mM NaN3, 5 AM
oligomycin, 5 Ag/ml antimycin A, 10 mM creatine phos-
phate, 8U/ml creatine kinase, and 1 ACi/ml of 45CaCl2,
adjusted with Tris/HCl to pH 7.0 at 25 jC. 45Ca2 + uptake
into the vesicles was initiated by the addition of K2ATP at a
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uptake had been reached, ryanodine, caffeine, cADPR or
FK506 was added to the medium. The drug-induced 45Ca2 +
release from the vesicles in the absence and that in the
presence of either cADPR or FK506 were compared. FK506
was dissolved in DMSO and was added from the stock
solution in a volume not exceeding 0.5%. For a control, the
vesicles were preincubated with the same volume of a
solvent (H2O or DMSO) instead of cADPR or FK506,
respectively. At indicated times, 45Ca2 + content of mem-
brane vesicles was determined by a rapid filtration technique
as described previously [8]. The radioactivity was counted
in a liquid scintillation counter (LS6500, Beckman).
Values are presented as meansF S.E. Statistical analysis
was performed using Student’s t-test.3. Results
3.1. Modulation of the ryanodine-sensitive mechanism by
cADPR
A steady state of 45Ca2 + uptake into pancreatic micro-
somal vesicles was reached about 20 min after the addition
of ATP (Fig. 1A). The amount of 45Ca2 + taken up into the
microsomal vesicles over a period of 20 min after the
addition of ATP was 4.3F 0.1 nmol/mg protein (n = 173).
Ryanodine (10 AM) was added to the vesicles after a steady
state of ATP-dependent 45Ca2 + uptake had been reached,
and the effect of cADPR (0.5 AM) on ryanodine (10 AM)-Fig. 2. Dose– response curves of caffeine (1–30 mM)-induced 45Ca2 +
release from pancreatic microsomes in the absence (Control; o) and
presence (.) of cADPR (0.5 AM). The experimental procedures were the
same as those described in the legend to Fig. 1 except for the addition of
caffeine. The vertical line represents the ratio of released 45Ca2 + as
described in the legend to Fig. 1B. Each point is the meanF S.E. from 4 to
12 experiments. Note that cADPR shifted the dose– response curve of the
caffeine-induced 45Ca2 + release to the left. Asterisks indicate the level of
significant difference compared to the control without cADPR at the
corresponding caffeine concentration. *P < 0.05, **P < 0.01, ***P< 0.001.
Fig. 3. Effect of cADPR (0.5 AM) on FK506-induced 45Ca2 + release from
pancreatic microsomes. (A) Typical curves for FK506 (3 AM)-induced
45Ca2 + release from the microsomal vesicles in the absence and presence of
cADPR (0.5 AM). The experimental procedures were the same as those
described in the legend to Fig. 1A except for the addition of FK506. FK506
(3 AM) was added to the vesicles as indicated in the absence (Control; o)
and presence (.) of cADPR. (B) Dose– response curves of FK506 (0.1–10
AM)-induced 45Ca2 + release from the vesicles in the absence (o) and
presence (.) of cADPR (0.5 AM). The vertical line represents the ratio of
released 45Ca2 + as described in the legend to Fig. 1B. Each point is the
meanF S.E. from 4 to 11 experiments of the type shown in (A). Note that
cADPR shifted the dose– response curve of the FK506-induced 45Ca2 +
release upward. Asterisks indicate the level of significant difference
compared to the control without cADPR at the corresponding FK506
concentration. **P < 0.01, ***P < 0.001. Lineweaver–Burk plot analysis of
the FK506-induced 45Ca2 + release (inset) yielded Km values of 0.47 and
0.70 AM and Vmax values of 8.1% and 14.4% in the absence (o) and
presence (.) of cADPR, respectively.induced 45Ca2 + release from the vesicles was investigated.
Pretreatment of the vesicles with cADPR did not affect the
ATP-dependent 45Ca2 + uptake before the addition of rya-
nodine (Fig. 1A) but significantly increased the ryanodine
(10 AM)-induced 45Ca2 + release (Fig. 1A). The effect of
cADPR (0.5 AM) on the 45Ca2 + release induced by ryano-
dine (0.1–500 AM) is shown at each ryanodine concentra-
tion in Fig. 1B. Ryanodine was effective at 0.3 AM in the
presence of cADPR, and the ryanodine-induced release at
Fig. 4. Effect of FK506 (3 AM) on ryanodine-induced 45Ca2 + release from
pancreatic microsomes. (A) Typical curves for ryanodine (10 AM)-induced
45Ca2 + release from the microsomal vesicles in the absence and presence of
FK506 (3 AM). The experimental procedures were the same as those
described in the legend to Fig. 1A except for the preincubation with FK506.
Ryanodine (Ry., 10 AM) was added to the vesicles as indicated in the
absence (Control; o) and presence (.) of FK506. FK506 or the same
volume of DMSO as a control was added at the beginning of the
preincubation. (B) Dose– response curves of ryanodine (0.1–500 AM)-
induced 45Ca2 + release from the vesicles in the absence (Control; o) and
presence (.) of FK506 (3 AM). The vertical line represents the ratio of
released 45Ca2 + as described in the legend to Fig. 1B. Each point is the
meanF S.E. from 5 to 9 experiments of the type shown in (A). Note that
FK506 shifted the dose– response curve of the ryanodine-induced 45Ca2 +
release to the left. Asterisks indicate the level of significant difference
compared to the control without FK506 at the corresponding ryanodine
concentration. *P < 0.05, **P< 0.01, ***P< 0.001.
Fig. 5. Dose– response curves of caffeine (1–30 mM)-induced 45Ca2 +
release from pancreatic microsomes in the absence (Control; o) and
presence (.) of FK506 (3 AM). The experimental procedures were the same
as those described in the legend to Fig. 4 except for the addition of caffeine.
The vertical line represents the ratio of released 45Ca2 + as described in the
legend to Fig. 1B. Each point is the meanF S.E. from 4 to 12 experiments.
Note that FK506 shifted the dose– response curve of the caffeine-induced
45Ca2 + release to the left. Asterisks indicate the level of significant
difference compared to the control without FK506 at the corresponding
caffeine concentration. *P< 0.05, **P < 0.01, ***P < 0.001.
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(P < 0.05–0.001) stimulated by the presence of cADPR
(Fig. 1B). cADPR shifted the dose–response curve of the
ryanodine-induced 45Ca2 + release to the left (Fig. 1B). The
effect of cADPR (0.5 AM) on caffeine (1–30 mM)-induced
45Ca2 + release from the vesicles was also investigated.
cADPR significantly (P < 0.05–0.001) increased the release
at lower concentrations (1–10 mM) of caffeine and shifted
the dose–response curve of the caffeine-induced 45Ca2 +
release to the left (Fig. 2). The effect of FK506 on 45Ca2 +release from the vesicles was also investigated. When
FK506 (3 AM) was added to the vesicles in a steady state
of the ATP-dependent 45Ca2 + uptake, about 5% of the
45Ca2 + that had been taken up by ATP was released from
the vesicles (Fig. 3A). The presence of cADPR (0.5 AM)
significantly enhanced the FK506 (3 AM)-induced 45Ca2 +
release (Fig. 3A). The effect of cADPR (0.5 AM) on the
FK506 (0.1–10 AM)-induced 45Ca2 + release is shown at
each FK506 concentration in Fig. 3B. cADPR shifted the
dose–response curve of the FK506-induced 45Ca2 + release
upward. Lineweaver–Burk plot evaluation of the release
(Fig. 3B, inset) showed Km values of 0.47 and 0.70 AM and
Vmax values of 8.1% and 14.4% in the absence and presence
of cADPR, respectively.
3.2. Modulation of the ryanodine-sensitive mechanism by
FK506
The effect of FK506 on ryanodine-induced 45Ca2 + re-
lease from the vesicles was investigated. Preincubation of
the vesicles with FK506 (3 AM) did not affect the ATP-
dependent 45Ca2 + uptake (Fig. 4A) but significantly in-
creased the ryanodine (10 AM)-induced 45Ca2 + release (Fig.
4A). The effect of FK506 (3 AM) on the ryanodine (0.1–
500 AM)-induced 45Ca2 + release is shown in Fig. 4B. In the
presence of FK506, ryanodine was effective at 0.3 AM as it
was in the presence of cADPR (cf. Figs. 1B and 4B). FK506
significantly (P < 0.05–0.001) increased the ryanodine-in-
duced release at concentrations ranging from 1 to 100 AM
(Fig. 4B) and shifted the dose–response curve of the
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extent as that in the case of cADPR (cf. Figs. 1B and 4B).
The effect of FK506 (3 AM) on caffeine (1–30 mM)-
induced 45Ca2 + release from the vesicles was also investi-
gated. FK506 significantly (P < 0.05–0.001) enhanced the
release at lower concentrations (1–10 mM) of caffeine (Fig.
5) and shifted the dose–response curve of the caffeine-
induced 45Ca2 + release to the left by the same extent as that
in the case of cADPR (cf. Figs. 2 and 5). The effect of
FK506 (3 AM) on the 45Ca2 + release induced by cADPR
(0.5–10 AM) was also investigated. The presence of FK506
shifted the dose–response curve of the cADPR-induced
45Ca2 + release upward (Fig. 6). Lineweaver–Burk plot
analysis of the release (Fig. 6, inset) showed that FK506Fig. 6. Dose– response curves of cADPR (0.5–10 AM)-induced 45Ca2 + release fro
AM). The experimental procedures were the same as those described in the legend
ratio of released 45Ca2 + over an 11-min period after the addition of cADPR to the 4
to 9 experiments. Note that FK506 shifted the dose– response curve of the cADPR
difference compared to the control without FK506 at the corresponding cADPR c
cADPR-induced 45Ca2 + release (inset) yielded Km values of 1.7 and 1.7 AM and
FK506, respectively.increased the Vmax value from 8.7% to 16.4% without
affecting the Km value (1.7 AM).
3.3. Modulation of the ryanodine-sensitive mechanism by
both cADPR and FK506
To determine whether the stimulatory effect on ryano-
dine- or caffeine-induced 45Ca2 + release from the vesicles
by cADPR and that by FK506 are additive, the ryanodine
(30 AM)- or caffeine (10 mM)-induced 45Ca2 + release was
investigated in the presence of both cADPR (0.5 AM) and
FK506 (3 AM). The presence of both cADPR and FK506
enhanced the ryanodine (30 AM)- or caffeine (10 mM)-
induced 45Ca2 + release by the same extent as that in the casem pancreatic microsomes in the absence (o) and presence (.) of FK506 (3
to Fig. 4 except for the addition of cADPR. The vertical line represents the
5Ca2 + that had been taken up by ATP. Each point is the meanF S.E. from 4
-induced 45Ca2 + release upward. Asterisks indicate the level of significant
oncentration. *P< 0.05, **P< 0.01. Lineweaver–Burk plot analysis of the
Vmax values of 8.7% and 16.4% in the absence (o) and presence (.) of
Fig. 7. Effects of cADPR (0.5 AM), FK506 (3 AM) and cADPR+FK506 on
45Ca2 + release from pancreatic microsomes induced by ryanodine (30 AM)
or caffeine (10 mM). The experimental procedures were the same as those
described in the legends to (Figs. 1, 2, 4 and 5). cADPR, FK506 and the
same volume of solvents (H2O/DMSO) as a control were added at the
beginning of the preincubation. The 45Ca2 + release induced by ryanodine or
caffeine in the absence (Control) and that in the presence of cADPR alone,
FK506 alone or both cADPR and FK506 were compared. The vertical line
represents the ratio of released 45Ca2 + as described in the legend to Fig. 1B.
Each value is the meanF S.E. from four paired experiments. Note that the
ryanodine- or caffeine-induced 45Ca2 + release in the presence of both
cADPR and FK506 was nearly the same as that in the presence of either
cADPR or FK506.
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stimulatory effects on the release by cADPR and by
FK506 were not additive, it is possible that cADPR and
FK506 modulate the ryanodine-sensitive Ca2 + channel by
the same mechanism.4. Discussion
In the present study, it was demonstrated that cADPR and
FK506 modulate the ryanodine-sensitive Ca2 + channels of
rat pancreatic acinar cells by increasing the ryanodine or
caffeine sensitivity to the channel (Figs. 1, 2, 4 and 5). In
addition, it is possible that the mechanisms of modulation
by cADPR and by FK506 are the same, since cADPR
shifted the dose– response curve of the ryanodine- or
caffeine-induced 45Ca2 + release to the left by the same
extent as that in the case of FK506 (cf. Figs. 1B and 4B
or cf. Figs. 2 and 5, respectively), and the stimulatory effects
on ryanodine (30 AM)- or caffeine (10 mM)-induced 45Ca2 +
release by cADPR and by FK506 were not additive (Fig. 7).
To the author’s knowledge, this is the first report of FK506
sensitivity to Ca2 + release from microsomes prepared from
nonexcitable tissues.
cADPR not only activates the ryanodine-sensitive Ca2 +
channel [13–17] but also modulates the Ca2 + channel by
increasing the Ca2 + or caffeine sensitivity in sea urchin eggs
[18] and rat parotid glands [8]. In the modulator modelproposed by Lee et al. [34], cADPR modulates the Ca2 + or
caffeine effect on the RyR at an endogenous level. The
cADPR concentration (0.5 AM) used for the modulation of
ryanodine- or caffeine-induced 45Ca2 + release from rat
pancreatic microsomal vesicles is nearly the same as that
reported to be endogenous levels (0.2–0.68 AM cADPR) in
the rat brain, heart and liver tissues [35]. Regarding the
action of cADPR on the receptor, two specific cADPR-
binding proteins in sea urchin eggs have been identified
[19]. Molecular masses of the proteins (140 and 100 kDa)
are less than that of known RyR proteins (380 kDa). This
finding suggests that cADPR receptors are unknown var-
iants of RyR proteins or RyR accessory proteins.
FK506 is known to enhance Ca2 + release through the
RyR in skeletal muscle [20,21]. FK506 dissociates FKBP12
from the RyR–FKBP12 complex [20]. By the removal of
this accessory protein, the RyR exhibits subconductance
states [21], and the Ca2 + or caffeine sensitivity of the
channel is enhanced [20,24]. The FK506 concentration (3
AM) used for the modulation of the ryanodine-sensitive
mechanism in rat pancreatic acinar cells (Figs. 4–6) is
nearly the same as that required to dissociate FKBP12 from
the RyR complex in skeletal muscle [20]. Type 2 (cardiac
type) RyR associates FKBP12.6 as an accessory protein
[25–27]. Since a type 2 RyR isoform has been identified in
rat pancreatic acinar cells [36,37], FKBP12.6 may be
involved in the modulation by FK506 of Ca2 + release
through the RyR of pancreatic acinar cells.
It has been found that cADPR can bind to FKBP12.6 and
dissociate FKBP12.6 from pancreatic islet microsomes [27].
An antibody against FKBP12.6 has been shown to inhibit
activation of the ryanodine-sensitive Ca2 + release channel
induced not only by FK506 but also by cADPR in recon-
stituted vesicles of coronary arterial smooth muscle cells
[38]. These findings suggest that cADPR can dissociate
FKBP12.6 from the RyR–FKBP12.6 complex to activate or
modulate the Ca2 + channel. Since cADPR can play the
same role in the modulation of Ca2 + release through the
RyR in rat pancreatic acinar cells as FK506 can (Figs. 1, 2, 4
and 5), it is possible that cADPR modulates the RyR by
dissociating FKBP from the RyR. If cADPR modulates the
RyR by the same mechanism as that by which FK506
modulates the RyR, this can explain why the stimulatory
effect on ryanodine- or caffeine-induced 45Ca2 + release
from the vesicles by cADPR and that by FK506 were not
additive (Fig. 7).
However, it is doubtful whether the cADPR-induced
45Ca2 + release following pretreatment of the vesicles with
FK506 shown in Fig. 6 is due to the dissociation of FKBP
since it is thought that FKBP had been removed from the
RyR by FK506 before the addition of cADPR. cADPR-
induced responses caused by the dissociation of FKBP
should be reduced in the presence of FK506. Actually,
pretreatment with FK506 abolished the cADPR-induced
Ca2 + release from pancreatic islet microsomes [27] and
inhibited the cADPR-induced increase in open probability
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smooth muscle cells [38], while the presence of FK506 in
rat pancreatic acinar cells stimulated the cADPR-induced
45Ca2 + release from the vesicles (Fig. 6). Binding of 32P-
labeled cADPR to sea urchin egg homogenates was not
affected by the presence of FK506 (30 AM) [39]. This
finding suggests that cADPR-binding proteins of sea urchin
eggs are not FKBPs. An FKBP-independent mechanism
may be involved in the cADPR-induced 45Ca2 + release
shown in Fig. 6. The FK506-induced 45Ca2 + release fol-
lowing pretreatment with cADPR shown in Fig. 3 may also
not be due to the dissociation of FKBP as in the case of the
results shown in Fig. 6. FK506 is a compound with a
macrocyclic lactone ring structure. It has been shown that
rapamycin and ivermectin, macrocyclic lactone derivatives,
increased the open probability of FKBP12-stripped RyRs in
skeletal muscle [40,41]. This finding suggests that the
compounds activate the RyR by a mechanism other than
dissociation of FKBP. Avermectin B1a, another macrocyclic
lactone compound, is known to bind to the GABA receptor-
activated Cl channel [42,43]. The FK506-induced 45Ca2 +
release from the vesicles shown in Fig. 3 may be explained
by a direct activation of the RyR by FK506. Since the
cADPR- and FK506-induced 45Ca2 + release from the
vesicles was stimulated by the presence of FK506 and
cADPR, respectively (Figs. 3 and 6), the release induced
by cADPR or FK506 may be modulated by the dissociation
of FKBP from the RyR.
Further studies are needed to clarify what subtype of
FKBP is involved in modulation of the RyR in rat pancreatic
acinar cells and to obtain detailed information on the actions
of cADPR and FK506 on the RyR.Acknowledgements
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